Cediranib Completed Phase 3 Trials for Recurrent Glioblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00777153Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma